Favipiravir combined with tocilizumab in the treatment of corona virus disease 2019  Drug: favipiravir combined with tocilizumab, drug: favipiravir, drug: tocilizumab  China, COVID‐19  150, all, 18–65  Treatment  Experimental: favipiravir combined with tocilizumab group